ask="N/A"
ask_size="N/A"
average_daily_volume="247859"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="+0.04"
change_from_200_day_moving_average="5.76"
change_from_50_day_moving_average="0.20"
change_from_52_week_high="-2.84"
change_From_52_week_low="14.84"
change_in_percent="+0.14%"
close="28.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="13741000"
high="29.33"
high_52_weeks="31.80"
last_trade_date="1/6/2017"
last_trade_price="28.96"
last_trade_size="5369"
last_trade_time="4:00pm"
low="28.65"
low_52_weeks="14.12"
market_capitalization="620.67M"
moving_average_200_day="23.19"
moving_average_50_day="28.76"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="29.08"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="+24.85%"
percent_change_from_50_day_moving_average="+0.71%"
percent_change_from_52_week_high="-8.93%"
percent_change_from_52_week_low="+105.10%"
previous_close="28.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.64"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="2.48"
stock_exchange="NMS"
symbol="ACRS"
volume="121962"
weeks_range_52="14.12 - 31.80"
